Terminated NA INTERVENTIONAL 1-arm NCT01816633

Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers

A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers

Sponsor: Cytomedix

Conditions Diabetic Foot Ulcers

Interventions AutoloGel

Updated 5 times since 2017 Last updated: Oct 19, 2016 Started: Oct 31, 2013 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Protocol study design was re-done in collaboration with CMS

Other terminated trials from Cytomedix

More terminations from Cytomedix

Other Diabetic Foot Ulcers trials with similar outcome

Browse all Diabetic Foot Ulcers trials

A NA clinical study on Diabetic Foot Ulcers, this trial is terminated or withdrawn. The trial is conducted by Cytomedix and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cytomedix

Data source: Cytomedix

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arcadia, United States
• Cumming, United States